Ultra-slow N-Acetyltransferase 2 Is Associated with Recurrence-free Time in Bladder Cancer Patients

Eur Urol. 2017 Jun;71(6):994-995. doi: 10.1016/j.eururo.2016.12.007. Epub 2016 Dec 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetylation
  • Arylamine N-Acetyltransferase / genetics*
  • Arylamine N-Acetyltransferase / metabolism
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Case-Control Studies
  • Disease-Free Survival
  • Haplotypes
  • Humans
  • Neoplasm Recurrence, Local / genetics*
  • Odds Ratio
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Risk Factors
  • Smoking / adverse effects
  • Smoking / genetics
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder Neoplasms / enzymology
  • Urinary Bladder Neoplasms / genetics*
  • Urinary Bladder Neoplasms / therapy

Substances

  • Biomarkers, Tumor
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human